ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Steroid Withdrawal Using Everolimus in Maintenance Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus.

    K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.

    Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan

    Background: Although steroid withdrawal from conventional immunosuppressive therapy has been attempted to ameliorate various complications, especially diabetes mellitus (DM), in kidney transplant recipients, a steroid-sparing…
  • 2017 American Transplant Congress

    A Prospective Observational Study to Evaluate Use of a Panel of Reactive T Cell (PRT) Assay as a Pre-Transplant Marker of Rejection in Kidney Transplant Recipients.

    D. Brennan,1 L. Kayler,2 D. Wojciechowski,3 A. Limaye,4 A. Gaber,5 I. Durrant.6

    1Washington University, St. Louis, MO; 2Erie County Medical Center, Buffalo, NY; 3Massachusetts General Hospital, Boston, MA; 4Washington University, Seattle, WA; 5Houston Methodist, Houston, TX; 6Oxford Immunotec, Oxfordshire, United Kingdom

    Background:To assess risk of T cell mediated acute rejection a recently developed assay uses a panel of reactive T cell lines (PRT) to measure recipient…
  • 2017 American Transplant Congress

    Change in QTC Interval After Kidney Transplant.

    E. Lai, V. Acharya, D. Nguyen, E. Graviss, W. Suki.

    Houston Methodist Hospital, Houston, TX

    Cardiovascular (CV) disease is the leading cause of mortality in ESRD patients. A prolonged QTc interval on EKG is a predictor of adverse CV outcomes.…
  • 2017 American Transplant Congress

    Donor Creatinine and Graft Outcomes in Pediatric Kidney Transplant Recipients.

    N. Hayde, M. Del Rio.

    Montefiore Medical Center, Bronx, NY

    Background: The role of donor peak and terminal creatinine on short and long term allograft outcomes in pediatric kidney transplant recipients is unclear.Aim: To determine…
  • 2017 American Transplant Congress

    Long-Term Clinical Outcomes of Kidney Transplant Recipients with Body-Size Mismatch Between Recipient and Donor.

    Y. Takada,1 D. Iwami,1 K. Hotta,1 K. Kanagawa,2 H. Higuchi,1 T. Hirose,1 H. Sasaki,1 N. Shinohara.1

    1Urology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan; 2Urology, Asahikawa City Hospital, Asahikawa, Hokkaido, Japan

    [Purpose]In living-donor kidney transplantation between large recipient and small donor, there are concerns of lower graft function and poor graft survival. Thus, we aimed to…
  • 2017 American Transplant Congress

    Impact of Type of Kidney (Living vs. Deceased) on Urinary Podocyte Excretion Rate in Renal Allografts.

    A. Naik, D. Luan, D. Cibrik, M. Samaniego, K. Woodside, M. Chowdhury, S. Wang, R. Wiggins.

    U Michigan, Ann Arbor

    Aim: Long term allograft survival has not improved.Surveillance biopsy studies have demonstrated that chronic microcirculatory injury and progressive glomerulosclerosis are the most common histological finding…
  • 2017 American Transplant Congress

    The Incremental of Cost of Incompatible Living Donor Kidney Transplant: A National Cohort Analysis.

    D. Axelrod,1 K. Lentine,2 M. Schnitzler,2 H. Xiao,2 X. Lou,3 B. Orandi,3 J. Garonzik Wang,3 A. Massie,3 D. Segev.3

    1Surgery, East Carolina University, Greenville, NC; 2Transplant, Saint Louis University, St. Louis, MO; 3Surgery, Johns Hopkins University, Baltimore, MD

    Incompatible living donor kidney transplant (ILDKT) has been established as an effective option for patients with willing but human leukocyte antigen incompatible live donors, reducing…
  • 2017 American Transplant Congress

    Impact of Dialysis During the Transplant Admission on Transplant and Post-Transplant Cost of Care.

    J. Tao,1 C. Horstman,1 W. Bannister,1 M. Schnitzler,2 F. Irwin,1 A. Bonagura,1 B. Laihinen.1

    1Complex Medical Conditions, Optum, UnitedHealth Group, Eden Prairie, MN; 2Surgery, St Louis University, St Louis, MO

    This study examines the impact of dialysis during the transplant admission on total cost of transplant and one year post-transplant care for kidney, liver, and…
  • 2017 American Transplant Congress

    mTOR Inhibition Diminishes Peripheral Blood CD8+CD28–CD38hi Effector/Memory T Cells and Facilitates Resolution of Belatacept-Refractory Kidney Rejection.

    C. Castro-Rojas,1 A. Godarova,1 A. Leino,2 R. Alloway,2 M. Jordan,3 E. Woodle,2 D. Hildeman.1

    1Division of Immunobiology, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH; 2Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH; 3Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Research Foundation, Cincinnati, OH

    Belatacept, a CD28-CD80/86 blocker, was approved by the FDA to provide immunosuppression without nephrotoxicity or cardiovascular and metabolic adverse effects. As part of our multi-center…
  • 2017 American Transplant Congress

    HLA Eplet Mismatches Predict DSA Formation, Graft Survival, and Re-Transplantation Rate in Pediatric Renal Transplantation.

    M. Sypek,1,2 S. Hiho,3 L. Cantwell,3 P. Hughes,2 A. Le Page,4 J. Kausman.1

    1Royal Children's Hospital, Melbourne, Australia; 2Royal Melbourne Hospital, Melbourne, Australia; 3Victorian Transplant and Immunogenetics Service, Melbourne, Australia; 4Monash Children's Hospital, Melbourne, Australia

    The potential benefits of HLA epitope based matching are greatest for pediatric recipients, however, there is little published data on the association of epitope mismatches…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences